Lotion, Cream, Gel, and Ointment Similarly Effective for Childhood Eczema

THURSDAY, June 2, 2022 (HealthDay News) -- There are no differences in effectiveness between the four main types of moisturizers for childhood eczema, according to a study published online May 23 in The Lancet Child & Adolescent Health.
Matthew J. Ridd, Ph.D., from the University of Bristol in the United Kingdom, and colleagues compared the clinical effectiveness and safety of the four main emollient types. Children (aged 6 months to 12 years) with eczema were randomly assigned to lotions (137 children), creams (140 children), gels (135 children), and ointments (138 children).
The researchers observed no difference in eczema severity between emollient types over 16 weeks. Results remained unchanged even with multiple imputation, sensitivity, and subgroup analyses. There were also no differences seen in total number of adverse events between the treatment groups (36, 39, 40, and 35 percent for lotions, creams, gels, and ointments, respectively). However, stinging was less common with ointments (9 percent) compared with lotions (20 percent), creams (17 percent), and gels (19 percent).
"A study of this type has been long overdue. It has not been in the interest of the manufacturers to directly compare types of moisturizer in the way we have done in this trial," Ridd said in a statement. "Our findings challenge conventions about how often moisturizers need to be applied, which types are less likely to cause problems and which patients should be recommended certain types."
Related Posts
Systemic Hormone Therapy During Menopause May Up Risk for Depression
FRIDAY, Nov. 4, 2022 (HealthDay News) -- Systemically administered hormone...
Blood Protein Might Predict Future Risk of Diabetes, Cancer
FRIDAY, Aug. 5, 2022 (HealthDay News) -- Elevated levels of a specific protein...
2019 to 2022 Saw Increase in Mental Health Service Use, Spending
MONDAY, Aug. 28, 2023 (HealthDay News) -- From 2019 to 2022, there was a...
Un panel asesor de la FDA se reunirá para hablar sobre las dosis de refuerzo contra la COVID
VIERNES, 17 de septiembre de 2021 (HealthDay News) -- Los asesores de la...